Efficacy and Safety of Lacidipine in Chronic Stable Angina
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study was to explore whether lacidipine at doses of 2 mg, 4 mg and 6 mg
decreased the symptoms of angina, compared to placebo in patients with chronic stable angina